VolitionRx Revenue and Competitors

Austin, TX USA

Location

#5533

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • VolitionRx's estimated annual revenue is currently $14.9M per year.(i)
  • VolitionRx's estimated revenue per employee is $122,975
  • VolitionRx's total funding is $27.2M.

Employee Data

  • VolitionRx has 121 Employees.(i)
  • VolitionRx grew their employee count by 1% last year.

VolitionRx's People

NameTitleEmail/Phone
1
CEO, Singapore VolitionReveal Email/Phone
2
VP Regulatory and Clinical DevelopmentReveal Email/Phone
3
IP Officer, European Patent AttorneyReveal Email/Phone
4
EVP Investor Relations & CFOReveal Email/Phone
5
Head FP&AReveal Email/Phone
6
Non Executive DirectorReveal Email/Phone
7
Chief Scientific OfficerReveal Email/Phone
8
Chief Operating OfficerReveal Email/Phone
9
Chief Marketing & Communications OfficerReveal Email/Phone
10
Chief Technology OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is VolitionRx?

Volition is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of Nucleosomics(TM), which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics. Volition's research and development activities are centered in Belgium, with additional offices in Texas, London and Singapore, as the company focuses on bringing its diagnostic products to market. For more information about Volition, visit Volition's website volition.com

keywords:N/A

$27.2M

Total Funding

121

Number of Employees

$14.9M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

VolitionRx News

2022-03-30 - VolitionRx Limited Announces Full Fiscal Year 2021 Financial ...

AUSTIN, Texas, March 30, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a...

2022-03-30 - VolitionRx makes ‘good progress" in key areas as it ends 2021 with over $20M in cash

Volition is a multi-national epigenetics company that has developed simple, easy-to-use, cost-effective blood tests to help diagnose and monitor...

2022-03-22 - VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings ...

AUSTIN, Texas, March 28, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on...

2021-11-11 - VolitionRx Limited Announces Third Quarter 2021 Financial Results and Business Update - Form 8-K

VolitionRx Limited Announces Third Quarter 2021 Financial Results and Business Update Conference call to discuss financial and operational results scheduled for Thursday, November 11, at 8:00 a.m. U.S. Eastern Time · Healthy balance sheet with approximately $22.9 million in cash and cash equ ...

2021-08-11 - VolitionRx : Announces Second Quarter 2021 Financial Results and Business Update (Form 8-K)

VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update Conference call to discuss financial and operational results scheduled for Thursday, August 12, at 8:00 a.m. U.S. Eastern Time · Strong balance sheet with approximately $27.9 million in cash and cash equiv ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.4M1216%N/A
#2
$24.4M121-10%N/A
#3
$14.5M1216%N/A
#4
$32.7M121-7%N/A
#5
$15.7M12134%$60M